# Row1 Inc. dba Regenative Labs – FDA Inspection, Mar 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/row1-inc-dba-regenative-labs/e4b46d9e-2a41-4147-9e55-8aae3004143a
Source feed: FDA_Inspections

> FDA inspection 1165813 of Row1 Inc. dba Regenative Labs, March 30, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165813
- Company Name: Row1 Inc. dba Regenative Labs
- Inspection Date: 2022-03-30
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

Company: https://www.keypedia.com/companies/row1-inc-dba-regenative-labs/f8c53372-486d-40ef-af57-16d200f99f62

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
